ReviR Therapeutics
Yang Liu's work experience includes serving as the VP of Computing at ReviR Therapeutics since October 2021. Prior to that, they worked as the Chief Technology Officer at Aegicare from March 2017 to October 2021. They also served as an Assistant Professor at Beijing 302 Hospital from June 2016 to March 2017.
Yang Liu attended Tsinghua University from 2006 to 2010, where they earned a Bachelor's degree in Computer Science and Technology.
This person is not in any offices
ReviR Therapeutics
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.